Clinical Trial Update: Galectin-3 Binding Protein in Cardiovascular Disease and Chronic Heart Failure

View source ↗

Summary

This entry reports the completion of a Heidelberg University–led clinical trial evaluating galectin-3 binding protein in heart failure and other cardiovascular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Coronary Artery Disease
• Heart Failure

Snippet

Sponsor: Heidelberg University | Conditions: Heart Failure, Cardiomyopathies | Status: COMPLETED